 | Up a level |
Journal Article
Kvasnicka, Hans Michael 
ORCID: 0000-0002-3081-1395, Thiele, Juergen, Bueso-Ramos, Carlos E., Sun, William, Cortes, Jorge, Kantarjian, Hagop M. and Verstovsek, Srdan
(2014).
Long-Term Effects of Ruxolitinib on Bone Marrow Morphology in Patients With Myelofibrosis and Comparison to Best Available Therapy.
Clin. Lymphoma Myeloma Leuk., 14.
S. S155 - 1.
DALLAS:
CIG MEDIA GROUP, LP.
ISSN 2152-2669
Kvasnicka, Hans Michael ORCID: 0000-0002-3081-1395, Thiele, Juergen, Bueso-Ramos, Carlos E., Sun, William, Cortes, Jorge, Kantarjian, Hagop M. and Verstovsek, Srdan
(2015).
Long-term bone marrow stromal changes in patients with myelofibrosis treated with ruxolitinib.
Clin. Lymphoma Myeloma Leuk., 15.
S. S234 - 1.
DALLAS:
CIG MEDIA GROUP, LP.
ISSN 2152-2669
Kvasnicka, Hans Michael, Thiele, Juergen, Bueso-Ramos, Carlos E., Sun, William, Cortes, Jorge ORCID: 0000-0002-8636-1071, Kantarjian, Hagop M. and Verstovsek, Srdan
(2018).
Long-term effects of ruxolitinib versus best available therapy on bone marrow fibrosis in patients with myelofibrosis.
J. Hematol. Oncol., 11.
LONDON:
BMC.
ISSN 1756-8722
Kvasnicka, Hans Michael ORCID: 0000-0002-3081-1395, Thiele, Juergen, Bueso-Ramos, Carlos E., Sun, William, Cortes, Jorge E., Kantarjian, Hagop M. and Verstovsek, Srdan
(2014).
Ruxolitinib-Induced Modulation of Bone Marrow Microenvironment in Patients with Myelofibrosis Is Associated with Inflammatory Cytokine Levels.
Blood, 124 (21).
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 1528-0020